POLISCOPE
Back to feed
NewsSan Diego Business JournalAugust 10, 2026San Diego

Inocras, Inc. Announces Domestic Expansion Plans in San Diego

Inocras, Inc., a company specializing in whole genome sequencing and cancer analytics, is shifting its focus toward domestic growth after establishing a presence in South Korea and Hong Kong. The company currently provides its CancerVision and MRDVision platforms to over 100 cancer institutions in Asia.

biotechnologybusiness expansioncancer researchSan Diego economy
Read the full story at San Diego Business Journal

Why It Matters

The expansion of a specialized biotechnology firm into the San Diego market may impact local employment and the regional life sciences research ecosystem.

Key Facts

  • Inocras, Inc. is transitioning from an Asia-focused business model to domestic expansion.
  • The company currently serves over 100 cancer institutions in Asia.
  • The company's primary products are the CancerVision and MRDVision platforms.
  • The company specializes in whole genome sequencing data and analytics.

Who's Mentioned

organizationInocras, Inc.“Biotech company formerly known as Genome Insight.”organizationMass General Brigham Cancer Institute“Potential academic medical center partner.”locationSouth Korea“Existing international market for the company.”organizationDana-Farber Cancer Institute“Potential academic medical center partner.”personJehee Suh“CEO of Inocras, Inc.”locationHong Kong“Existing international market for the company.”organizationUC San Diego Health“Potential academic medical center partner.”locationSan Diego“The location of the company's domestic expansion.”